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Abstract: Atherosclerosis, the pathophysiological substrate for cardiovascular disease (CVD), is the final stage of an 
inflammatory cascade. During the process, endothelial dysfunction ensues and the inflammatory state is perpetuated. A 
number of traditional risk factors, as obesity and insulin resistance/type 2 diabetes, are characterized by a 
proinflammatory state as well, with increased levels of cytokines, interleukins, vasoactive peptides and enhanced 
expression of specific cellular receptors. The anti-inflammatory properties of physical exercise and its positive effects as 
a strategy for obesity and insulin resistance have already been shown in terms of cardiovascular protection and survival. 
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INTRODUCTION 
“Low-grade” chronic inflammation is related to 
chronic diseases. Cardiovascular risk factors, like 
hypertension, excess of adiposity (mainly visceral), 
physical inactivity, inadequate alimentation and 
hyperlipidemia can precede the inflammatory process. 
These behavioral and biochemical factors predispose 
the individual to insulin resistance and type 2 diabetes 
mellitus (T2DM), and, consequently, to endothelial 
dysfunction and atherosclerosis. Therefore, the 
quantification of serological markers emerged as an 
important tool for a better understanding of the 
pathological process, diagnosis and prognosis of the 
inflammatory status. It is also useful in evaluating and 
monitoring the effects of therapeutic strategies, like 
exercise.  
ENDOTHELIAL DYSFUNCTION AND ATHERO 
SCLEROSIS - THE ROLE OF INFLAMMATORY 
MARKERS 
For many years, atherosclerosis was thought to be 
simply the accumulation of lipids in the arterial wall.  
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Although elevated plasmatic levels of cholesterol - 
especially its low-density lipoprotein fraction, LDL - is a 
well established risk factor, it is now known that the 
atherosclerotic process is more than that. 
Atherosclerosis is an inflammatory disease [1].  
There is a large body of evidence sustaining the 
central role played by endothelial dysfunction in the 
pathophysiology of atherosclerosis. The endothelium is 
a single-cell lining covering the internal surface of blood 
vessels. It behaves as a receptor-effector structure, 
capable of sensing different stimulus (physical or 
chemical) that occur inside the vessel and, therefore, 
acts modifying the vessel shape or releasing the 
necessary substances to maintain homeostasis. The 
endothelium produces and releases both agonists and 
antagonists molecules (pro- and anti-inflammatory, pro- 
and anticoagulants, vasodilators and vasoconstrictors, 
fibrinolytics and antifibrinolytics, oxidizing and 
antioxidizing) [1-3]. Endothelial dysfunction ensues 
when this balance is disrupted, as in the presence of 
classic cardiovascular risk factors (e.g. hypertension, 
diabetes, smoking, high LDL-cholesterol levels, 
obesity). It represents a reduction in endothelial-
mediated vasodilatation and a pro-inflammatory/pro-
thrombotic state of the endothelium [4]. 
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Once dysfunction takes place, the endothelium is no 
longer capable of fully preserve its homeostatic 
properties, and thrombosis is facilitated. There is 
reduction of nitric oxide (NO) synthesis and increased 
angiotensin II response; in addition, leukocytes 
(monocytes and T-lymphocytes) adhere to the 
endothelial cells and migrate into the intima [5]. The 
result is amplification and chronification of the 
inflammatory response [6-9].  
In time, the initial stage of atherosclerotic lesion - 
fatty streak - appears. As the disease evolves, modified 
lipids and inflammatory cells and mediators accumulate 
further in the vessel intima as atheromatous plaques, 
which may reduce vascular flow by chronic stenosis (or 
acute thrombosis). The compensatory increase of 
blood flow velocity is responsible for the so-called 
shear stress in the vascular wall, being the main 
stimulus for NO release and, finally, for endothelium-
mediated vasodilatation (EMD) - or flow-mediated 
dilation (FMD). Nevertheless, this adaptive response is 
inhibited in hyperadrenergic states - characteristic of 
conditions such as hypertension [10, 11] and sleep 
apnea [12-14], for example. 
There is evidence of the benefits of such conditions` 
treatment on endothelial dysfunction [15-20]. The use 
of biochemical markers of inflammatory response as 
cardiovascular risk predictors has been extensively 
studied, with conflicting results so far [21-28]. On the 
other hand, data regarding FMD as an indicator of 
endothelial dysfunction and cardiovascular risk are 
more robust.  
INFLAMMATORY MEDIATORS IN OBESITY AND 
INSULIN RESISTANCE 
Adipose tissue is an important endocrine organ 
involved in a number of metabolic, immunological and 
neuroendocrine reactions. It is known that obesity is 
related to a chronic inflammatory state. This, in turn, is 
deeply connected to the presence of a series of 
serological markers that act as mediators of obesity-
related inflammation.  
Firstly, the adipocyte - the cellular unit of adipose 
tissue - secretes adipokines, which play a central role 
in inciting and perpetuating the inflammatory process in 
obesity. Also, considerable levels of tumor necrosis 
factor - are present on fat tissue [29]. Besides, 
alimentary factors can play a role in the 
pathophysiology of this condition, once fatty acids are 
capable to interact with toll-like receptors (TLRs), 
activating nuclear factor kappa B (NFB) and 
promoting its translocation to the cellular core, where it 
regulates the expression of a variety of genes involved 
in the pro-inflammatory process [30]. 
In fact, there is evidence that modifications on the 
adipocyte-signaling process and infiltration of immune 
system`s cells present in the adipose mass may be the 
link between obesity and conditions as insulin 
resistance - and, consequently, endothelial dysfunction 
(Figure 1)[31]. 
Insulin resistance is related to a pro-inflammatory 
state that results from release of cytokines and the 
consequent intra-cellular signaling modifications in key-
organs for glycemic control (e.g. liver, striated muscle 
and adipose tissue) [32]. One of these alterations is the 
sequential activation of a series of kinase proteins, like 
nuclear factor kappa-B kinase subunit beta (IKK-), 
protein kinase C (PKC) and c-Jun N-terminal kinase 
(JNK). These proteins cause the reduction of 
phosphatidylinositol 3-kinase (PI3-K) activity, thus, 
downregulating the transport of glucose. Additionally, 
there is the dissociation of the I/NFB complex in the 
cytoplasm, by the IKK- enzyme, what allows its 
migration to the cellular nucleus, enhancing the 
negative effects on the insulin-signaling pathway [33].  
The resultant hyperglycemia has acute and chronic 
effects on the production of pro-inflammatory cytokines. 
Previous studies demonstrated that subjects with 
glucose intolerance have high baseline values of TNF-
 and interleukin-6, as compared to their respective 
controls. Moreover, these subjects present a high and 
sustained release of cytokines in response to 
hyperglycemic peaks [34], contributing to this vicious 
cycle of more inflammation/more insulin resistance. 
Another mechanism linking these two conditions is that 
acute inflammatory stress can affect the non-insulin-
dependent glucose availability regulation pathways, as 
the activation of 5' adenosine monophosphate-
activated protein kinase (AMPK)[35]. 
Nevertheless, inflammation and insulin resistance 
are not only connected by cytokines and kinase 
proteins. It is suggested that a special group, the heat 
shock proteins (HSP) have also an important role in the 
insulin resistance process mediated by inflammation, 
once diabetic obese individuals have higher circulating 
levels of HPS. [36]. 
PHYSICAL EXERCISE AND ENDOTHELIAL 
DYSFUNCTION: THE ROLE OF HEAT SHOCK 
PROTEINS (HPS) 
Exercise represents a physiological stress condition 
to the cardiovascular system. It induces acute and 
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Figure 1: Interaction between adipose tissue, insulin resistance and endothelial dysfunction. Monocyte chemotactic protein 1 
(MCP-1) are released from full visceral adipocytes, which increases the macrophage recruitment into the adipose tissue 
establishing an inflammatory process. Higher levels of TNF-  and IL-6 stimulate the production of CRP by the liver and these 
adipokines promote insulin resistance and endothelial dysfunction directly or indirectly. Endothelium releases biomarkers as PAI-
1 and ICAM-1 in response to other injuries as LDL-ox and ROS, contributing to the vicious circle. (Adapted from Van Gaal LF et 
al.)[31]. 
 
Figure 2: Effects of the sedentary behavior and physical exercise (mediated by inflammatory status) over adipose tissue and 
glycemic control. 
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chronic modifications on endothelial cell morphology 
and biochemistry. This adaptive process is affected by 
each exercise session and by physical conditioning 
levels [37].  
There is evidence that the activation of HSP 
induced by exercise may play important roles in 
vascular functioning [38]. These are highly conserved 
proteins categorized in families according to their 
molecular sizes and include HSP110, HSP100, HSP90, 
HSP70, HSP60 HSP30 and HSP10 subclasses.  
HSP facilitates intracellular protein transport, 
prevent protein aggregation during folding, and protect 
newly synthesized polypeptide chains against 
misfolding and protein denaturation. The expression of 
HSP in different parts of the cardiovascular system 
(e.g. cardiac muscle, arterial wall) is crucial for its role 
in cardiovascular protection [39]. 
Regular exercise promotes acute increase of blood 
flow. This leads to augmented shear stress and, 
consequently, higher ˙NO bioavailability, increasing the 
endothelium-dependent vasodilatation. This occurs in 
parallel to the decrease in pro-inflammatory markers 
after exercise training. This increase in NO and 
decrease in pro-inflammatory markers could represent 
one of the most important mechanisms of cardio 
protection induced by regular exercise [37]. 
Higher levels of inflammatory markers - as IL-6 and 
C-reactive protein (CRP) are related to reductions in 
NO concentrations caused by reduced eNOS activity 
[40]. This, in turn, is associated to cardiovascular 
disease progression. This extracellular pro-
inflammatory signaling pathway is enhanced in obesity 
and T2DM. HSP70 levels are also associated with 
biomarkers of acute-phase reaction, inflammation and 
endothelial-cell activation, suggesting an interaction 
between HSP70 and receptors in the surface of 
immune cells. Free radicals, ox-LDL and other factors 
can stimulate the expression of HPS in the arterial wall 
and/or other tissues, which are protected by high levels 
of HPS against apoptosis [39].  
Low levels of intracellular and high levels of 
circulating HSP70 promote a proinflammatory state and 
increase the vulnerability of the arterial wall-the first 
stage of the development of the atherosclerotic 
process. Serum HSP70 (eHSP70) rises the expression 
of adhesion molecules in smooth muscle cells and in 
macrophages, inducing cellular proliferation and the 
release of proinflammatory cytokines [39].  
Levels of plasma anti-HSP70 are significantly 
increased in atherosclerotic rats. These antibodies 
could react with endothelial surface membrane HSP70 
and could mediate endothelial cytotoxicity, 
demonstrating a possible involvement of humoral 
immune reaction to Hsp70 with the pathogenesis of 
atherosclerosis [41]. 
In this way, it can be said that intracellular and 
extracellular HSP70 have different roles in the 
regulation of cardiovascular homeostasis. Also, while 
exercise can induce both intracellular and extracellular 
HSP70, and then promotes equilibrium in HSP 
signaling to cardiovascular system, the process of 
immune-metabolic disease such as atherosclerosis can 
promote a higher extracellular proinflammatory 
signaling and decrease cytoprotection HSP function in 
many cells and tissues, as the endothelial cells. 
EXERCISE AS ANTI-INFLAMMATORY STRATEGY 
IN OBESITY AND INSULIN RESISTANCE 
Physical inactivity promotes accumulation of 
visceral fat and, consequently, activates a series of 
pro-inflammatory signaling cascades that participate in 
the development process of insulin resistance, 
atherosclerosis and CVD. The best demonstration that 
physical exercise, when regularly adopted, may be a 
therapeutic strategy against chronic disease such as 
obesity and T2DM is its capacity to prolong life [42]: 
meta-analyses of randomized controlled trials with 
mortality outcomes comparing the effectiveness of 
exercise and drug interventions with each other or with 
control (placebo or usual care) shows that exercise and 
many drug interventions are often potentially similar in 
terms of their mortality benefits in the secondary 
prevention of coronary heart disease, rehabilitation 
after stroke, treatment of heart failure, and prevention 
of T2DM [43]. 
The decrease in levels of inflammatory markers 
related to excercise seems to be independent of weight 
loss. After six weeks of regular physical training (60% 
of maximum heart rate) in overweight subjects (body 
mass index - BMI -  30kg/m2), a 57%-increase of 
natural killer (NK) cells cytolytic activity was observed, 
independently of weight loss [44]. On the other hand, 
weight loss (~8kg) in persons with grade 1 obesity (BMI 
~33kg/m2) submitted to caloric restriction (12 weeks, 
~1200kcal/day) led to impaired mithogen-stimulated 
linfocytary proliferation, with no effects on monocytes, 
NK cells or neutrophils. Noteworthy is the fact that a 
more severe caloric restriction (950kcal/day), even for 
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a shorter period (8 weeks), in subjects with grade 2 
obesity (BMI~36kg/m2), not only resulted in an 11% 
weight loss (~10kg) but also reduced the activity of NK 
cells in 50% [45]. 
Nevertheless, even when accompanied by physical 
exercise (60-80% of peak HR) for 2 months, more 
pronounced weight loss (5.4-8.4 kg) does not promote 
a significant reduction in CRP levels; on the contrary, a 
moderate loss (2.3-5.4 kg) is associated with a more 
effective decrease in the concentration of this 
inflammatory marker [46]. Although BMI is a predictor 
of IL-1 and IL-6 levels in subjects from the eutrophic 
to obesity range, increased aerobic capacity is related 
to lower levels of both markers and to a better 
response of monocytes to adrenergic stimulus, 
indicating the importance of physical conditioning in the 
immunological status in overweight and obese 
individuals [47]. Also, physical training may be 
beneficial by reducing TNF- expression in 
macrophages.  
In T2DM, from the more incipient stages of disease 
to its complications, the pro-/anti-inflammatory and the 
redox status are involved, and the Th1-lymphocytes 
are stimulated to express inducible nitric oxide 
synthase (iNOS). This happens in response to NFB 
over activation, what imposes an enhanced flow of L-
arginine through the iNOS pathway, the only form of 
NOS expressed in pancreatic  cells. Consequently, 
the massive production of NO has devastating effects 
on these cells, which rely, mainly, on glutathione (GSH) 
for antioxidant protection. Glutamine is used for GSH 
synthesis, and its stores are compromised during 
inflammation. It is known that physical exercise 
increases the influx of glutamine, thus playing a role in 
preventing pancreatic  cells death [48]. Additionally, 
exercise decreases the levels of circulating TNF- as 
well as iNOS activity in persons with diabetes.  
The acute response to exercise is characterized by 
neutrophil degranulation, phagocytosis and increased 
production of reactive oxygen species (ROS) by the 
innate immune system. It can also reduce the 
expression of TLR-1, 2 and 4 in CD4 monocytes, thus 
diminishing the probability of interactions with IL-6, IL1-
 and TNF-. In one section of physical exercise it is 
observed a biphasic immune response, with an initial 
lymphocytosis and a later decrease in lymphocytes 
count. Consequently, there is a relative decrement in 
Th1 lymphocytes - which activates cellular proliferation 
by releasing IFN- and IL-2 - in comparison to Th2 cells 
- responsible for IL- 4, 5, 6 and 13 release, acting in the 
humoral immunity. Thus, both exercise intensity and 
duration have influence on immune response [37, 49].  
The release of TNF- causes inactivation of the 
intracellular signaling pathway of insulin on peripheral 
tissue receptors and consequently lowers the 
expression of HSP in the muscle cells. Physical 
exercise inhibits NFB and rise HSP levels [50], 
reinforcing the anti-inflammatory effect and benefits of 
the exercise over insulin resistance mediated by 
inflammation. Besides, HPS released during exercise 
acts reducing the expression of TNF-, IL-1, IL-12, IL-
10 and IL-18 genes [51]. On the other hand, 
immunologic system can synthesize and export HPS in 
stress situation, so called eHPS. During exercise 
eHSP70 is released proportionally to the intensity of 
the physical activity. Some functions of the extracellular 
eHSP70 are immunologic system activation, 
recruitment of NK cells, to stimulate cytokines release 
and NFkB activation [52]. Thus, HPS intra and 
extracellular levels promote a balance between Th1 
(proinflammatory) and Th2 (anti-inflammatory) cells in 
response to physical activity. HPS levels could also 
contribute to glycemic control, since its release occurs 
in hypoglycemic situations in response to a 
homeostatic stress [53]. 
CONCLUSION 
The relationship between CVD, obesity and insulin 
resistance/T2DM is well determined, and the available 
evidence about the role of inflammation as the 
underlying connection between such conditions is 
getting not only more numerous but also more robust. 
 Physical exercise was already prescribed as a 
strategy for a healthier lifestyle. In the last years, more 
concrete evidence of its benefits in terms of altering the 
pathophysiologial process of CVD has emerged, 
signaling that exercise has anti-inflammatory properties 
capable of counteract the hostile environment of 
endothelial dysfunction. 
Although more research is still needed, the present 
data support the use of exercise as a therapeutic 
strategy in persons with obesity and insulin resistance 
with the purpose of attenuate the inflammatory state 
characteristic of these entities and, thus, act on the 
pathological substrate of atherosclerosis. 
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